T1	CHEM 56 77	ácidos grasos omega 3
#1	AnnotatorNotes T1	C0015689; omega-3 fatty acids; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T2	DISO 108 139	estado inflamatorio y oxidativo
T3	PROC 144 187	estudio aleatorizado, cruzado y doble ciego
#2	AnnotatorNotes T3	C0150097; Cross-Over Studies; Research Activity + C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T4	CHEM 214 221	omega-3
#3	AnnotatorNotes T4	C0015689; omega-3 fatty acids; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T5	CHEM 507 514	omega-3
#4	AnnotatorNotes T5	C0015689; omega-3 fatty acids; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T6	PROC 286 296	prevención
#5	AnnotatorNotes T6	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T7	DISO 303 328	enfermedad cardiovascular
#6	AnnotatorNotes T7	C0007222; Cardiovascular Diseases; Disease or Syndrome
T8	DISO 330 333	ECV
#7	AnnotatorNotes T8	C0007222; Cardiovascular Diseases; Disease or Syndrome
T9	ANAT 603 617	cardiovascular
#8	AnnotatorNotes T9	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T10	PROC 654 690	ensayo clínico cruzado y doble-ciego
#9	AnnotatorNotes T10	C0150097; Cross-Over Studies; Research Activity + C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T11	PROC 766 803	marcadores de inflamación y oxidación
T12	PROC 864 879	perfil lipídico
#10	AnnotatorNotes T12	C0523744; Lipids measurement; Laboratory Procedure
T13	CHEM 871 879	lipídico
#11	AnnotatorNotes T13	C0023779; Lipids; Organic Chemical
T14	PROC 1133 1148	perfil lipídico
#12	AnnotatorNotes T14	C0523744; Lipids measurement; Laboratory Procedure
T15	DISO 910 913	ECV
#13	AnnotatorNotes T15	C0007222; Cardiovascular Diseases; Disease or Syndrome
T16	PROC 1150 1175	marcadores de inflamación
#14	AnnotatorNotes T16	C3805088; Inflammatory marker test; Laboratory Procedure
T17	PROC 1221 1244	marcadores de oxidación
T18	CHEM 1140 1148	lipídico
#15	AnnotatorNotes T18	C0023779; Lipids; Organic Chemical
T19	PROC 1177 1180	PCR
#16	AnnotatorNotes T19	C0201657; C-reactive protein measurement; Laboratory Procedure
T20	PROC 1182 1187	PAI-1
#17	AnnotatorNotes T20	C2825905; Plasminogen Activator Inhibitor-1 Measurement; Laboratory Procedure
T22	PROC 1200 1204	IL-6
#18	AnnotatorNotes T22	C0919829; Interleukin 6 Measurement; Laboratory Procedure
T23	PROC 1206 1217	fibrinógeno
#19	AnnotatorNotes T23	C0337428; Fibrinogen assay; Laboratory Procedure
T24	PROC 1448 1453	PAI-1
#20	AnnotatorNotes T24	C2825905; Plasminogen Activator Inhibitor-1 Measurement; Laboratory Procedure
T25	PROC 1455 1466	fibrinógeno
#21	AnnotatorNotes T25	C0337428; Fibrinogen assay; Laboratory Procedure
T26	PROC 1583 1587	FRAP
#22	AnnotatorNotes T26	[Ferric Reducing Antioxidant Power Assay]
T27	PROC 1565 1570	PAI-1
#23	AnnotatorNotes T27	C2825905; Plasminogen Activator Inhibitor-1 Measurement; Laboratory Procedure
T28	PROC 1737 1742	PAI-1
#24	AnnotatorNotes T28	C2825905; Plasminogen Activator Inhibitor-1 Measurement; Laboratory Procedure
T29	PROC 1781 1793	intervención
#25	AnnotatorNotes T29	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T30	CHEM 1905 1912	omega-3
#26	AnnotatorNotes T30	C0015689; omega-3 fatty acids; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T31	DISO 1851 1867	efectos adversos
#27	AnnotatorNotes T31	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T32	DISO 1944 1975	estado inflamatorio y oxidativo
T33	CHEM 2025 2033	lipídico
#28	AnnotatorNotes T33	C0023779; Lipids; Organic Chemical
T34	DISO 570 579	oxidación
#29	AnnotatorNotes T34	C0242606; Oxidative Stress; Cell or Molecular Dysfunction (?)
T35	PROC 2076 2093	dieta equilibrada
#30	AnnotatorNotes T35	C0452410; Balanced diet; Therapeutic or Preventive Procedure
T36	PROC 542 579	marcadores de inflamación y oxidación
T37	CHEM 80 98	extracto de romero
#31	AnnotatorNotes T37	C0939869; rosemary extract; Organic Chemical · Pharmacologic Substance
T38	ANAT 314 328	cardiovascular
#32	AnnotatorNotes T38	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T39	CHEM 517 535	extracto de romero
#33	AnnotatorNotes T39	C0939869; rosemary extract; Organic Chemical · Pharmacologic Substance
T40	DISO 556 567	inflamación
#34	AnnotatorNotes T40	C0021368; Inflammation; Pathologic Function
T41	DISO 780 791	inflamación
#35	AnnotatorNotes T41	C0021368; Inflammation; Pathologic Function
T42	PROC 1246 1251	TBARS
#36	AnnotatorNotes T42	[Thiobarbituric acid reactive substances]
T43	DISO 1164 1175	inflamación
#37	AnnotatorNotes T43	C0021368; Inflammation; Pathologic Function
T44	PROC 1253 1257	FRAP
#38	AnnotatorNotes T44	[Ferric Reducing Antioxidant Power Assay]
T45	PROC 1259 1270	8-iso-PGF2α
#39	AnnotatorNotes T45	C3900187; 8-Iso-Prostaglandin F2 Alpha Measurement; Laboratory Procedure
T46	PROC 1469 1480	8-iso-PGF2α
#40	AnnotatorNotes T46	C3900187; 8-Iso-Prostaglandin F2 Alpha Measurement; Laboratory Procedure
T47	PROC 1744 1748	FRAP
#41	AnnotatorNotes T47	[Ferric Reducing Antioxidant Power Assay]
T48	CHEM 1915 1933	extracto de romero
#42	AnnotatorNotes T48	C0939869; rosemary extract; Organic Chemical · Pharmacologic Substance
T49	DISO 596 617	riesgo cardiovascular
#43	AnnotatorNotes T49	C4324389; Cardiovascular Risk; Finding
T50	PROC 1498 1502	FRAP
#44	AnnotatorNotes T50	[Ferric Reducing Antioxidant Power Assay]
T51	PROC 1751 1762	8-iso-PGF2α
#45	AnnotatorNotes T51	C3900187; 8-Iso-Prostaglandin F2 Alpha Measurement; Laboratory Procedure
T52	PROC 2018 2033	perfil lipídico
#46	AnnotatorNotes T52	C0523744; Lipids measurement; Laboratory Procedure
T53	DISO 1235 1244	oxidación
#47	AnnotatorNotes T53	C0242606; Oxidative Stress; Cell or Molecular Dysfunction (?)
T54	DISO 794 803	oxidación
#48	AnnotatorNotes T54	C0242606; Oxidative Stress; Cell or Molecular Dysfunction (?)
T55	PROC 719 759	consumo de un producto cárnico funcional
T56	PROC 1887 1900	consumo de CF
T57	PROC 922 946	asignados aleatoriamente
#49	AnnotatorNotes T57	C0034656; Randomization; Research Activity
T58	LIVB 583 591	personas
#50	AnnotatorNotes T58	C0027361; Persons; Population Group
T59	LIVB 620 629	Pacientes
#51	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	LIVB 822 833	voluntarios
#52	AnnotatorNotes T60	C0020155; Human Volunteers; Population Group
T61	Duration 1036 1046	12 semanas
T62	Duration 1075 1084	4 semanas
T63	LIVB 1312 1320	personas
#53	AnnotatorNotes T63	C0027361; Persons; Population Group
T64	LIVB 1325 1332	mujeres
#54	AnnotatorNotes T64	C0043210; Woman; Population Group
T65	Age 1352 1365	50.7±8.8 años
T66	Duration 1392 1402	12 semanas
T67	LIVB 1979 1987	personas
#55	AnnotatorNotes T67	C0027361; Persons; Population Group
T68	Neg_cue 1848 1850	ni
T69	PHYS 241 265	efectos antinflamatorios
#56	AnnotatorNotes T69	C1516019; Antiinflammatory Effect; Physiologic Function
T21	PROC 1189 1198	TNF-alpha
#57	AnnotatorNotes T21	C4700807; TNF-alpha in serum or plasma; Laboratory Procedure
T70	Food 15 20	carne
#58	AnnotatorNotes T70	C0025017; Meat; Food
T71	Food 487 492	carne
#59	AnnotatorNotes T71	C0025017; Meat; Food
T72	Food 986 991	carne
#60	AnnotatorNotes T72	C0025017; Meat; Food
T73	Food 1009 1014	carne
#61	AnnotatorNotes T73	C0025017; Meat; Food
T74	Quantifier_or_Qualifier 992 1001	funcional
#62	AnnotatorNotes T74	C0205245; Functional; Functional Concept
T75	Quantifier_or_Qualifier 1015 1022	control
T76	Quantifier_or_Qualifier 21 30	funcional
#63	AnnotatorNotes T76	C0205245; Functional; Functional Concept
T77	Food 348 366	productos cárnicos
#64	AnnotatorNotes T77	C0025017; Meat; Food
T78	Quantifier_or_Qualifier 367 378	funcionales
#65	AnnotatorNotes T78	C0205245; Functional; Functional Concept
T79	Quantifier_or_Qualifier 493 502	funcional
#66	AnnotatorNotes T79	C0205245; Functional; Functional Concept
T80	Food 733 749	producto cárnico
#67	AnnotatorNotes T80	C0025017; Meat; Food
T81	Quantifier_or_Qualifier 750 759	funcional
#68	AnnotatorNotes T81	C0205245; Functional; Functional Concept
T82	Result_or_Value 880 888	alterado
T83	CONC 1054 1071	periodo de lavado
#69	AnnotatorNotes T83	C1710661; Washout Period; Temporal Concept
T84	CONC 1098 1121	Al finalizar el estudio
#70	AnnotatorNotes T84	C2983670; Study End Date; Temporal Concept
T85	Neg_cue 1794 1796	no
T86	Observation 1811 1847	cambios en variables antropométricas
T87	Result_or_Value 2034 2042	alterado
T88	Spec_cue 900 909	riesgo de
T89	CONC 1822 1847	variables antropométricas
A1	Assertion T31 Negated
R1	Has_Quantifier_or_Qualifier Arg1:T72 Arg2:T74
R2	Has_Quantifier_or_Qualifier Arg1:T73 Arg2:T75
R3	Has_Quantifier_or_Qualifier Arg1:T70 Arg2:T76
R4	Combined_with Arg1:T70 Arg2:T1
R5	Combined_with Arg1:T1 Arg2:T37
R6	Overlap Arg1:T4 Arg2:T69
R7	Used_for Arg1:T4 Arg2:T6
R8	Location_of Arg1:T38 Arg2:T7
R9	Location_of Arg1:T38 Arg2:T8
R10	Has_Quantifier_or_Qualifier Arg1:T77 Arg2:T78
R11	Has_Quantifier_or_Qualifier Arg1:T71 Arg2:T79
R12	Combined_with Arg1:T5 Arg2:T71
R13	Combined_with Arg1:T39 Arg2:T71
R14	Experiences Arg1:T58 Arg2:T49
R15	Experiences Arg1:T58 Arg2:T36
R16	Experiences Arg1:T58 Arg2:T40
R17	Experiences Arg1:T58 Arg2:T34
R18	Location_of Arg1:T9 Arg2:T49
R19	Has_Quantifier_or_Qualifier Arg1:T80 Arg2:T81
R20	Experiences Arg1:T59 Arg2:T55
R21	Experiences Arg1:T59 Arg2:T11
R22	Experiences Arg1:T59 Arg2:T41
R23	Experiences Arg1:T59 Arg2:T54
R24	Experiences Arg1:T60 Arg2:T12
R25	Has_Result_or_Value Arg1:T12 Arg2:T82
R26	Experiences Arg1:T60 Arg2:T15
R27	Has_Duration_or_Interval Arg1:T83 Arg2:T62
R28	Has_Duration_or_Interval Arg1:T73 Arg2:T61
R29	Has_Duration_or_Interval Arg1:T72 Arg2:T61
R30	Overlap Arg1:T14 Arg2:T84
R31	Overlap Arg1:T16 Arg2:T84
R37	Overlap Arg1:T17 Arg2:T84
R41	Has_Age Arg1:T63 Arg2:T65
R42	After Arg1:T24 Arg2:T66
R43	After Arg1:T25 Arg2:T66
R44	After Arg1:T46 Arg2:T66
R45	After Arg1:T50 Arg2:T66
A2	Assertion T86 Negated
R46	Negation Arg1:T85 Arg2:T86
R47	Negation Arg1:T68 Arg2:T31
R48	After Arg1:T86 Arg2:T29
R49	After Arg1:T31 Arg2:T29
R50	Combined_with Arg1:T56 Arg2:T30
R51	Combined_with Arg1:T30 Arg2:T48
R52	Experiences Arg1:T67 Arg2:T56
R53	Experiences Arg1:T67 Arg2:T32
R54	Has_Result_or_Value Arg1:T52 Arg2:T87
R55	Experiences Arg1:T67 Arg2:T52
R56	Experiences Arg1:T58 Arg2:T5
R57	Experiences Arg1:T58 Arg2:T39
R58	Causes Arg1:T40 Arg2:T49
R59	Causes Arg1:T34 Arg2:T49
R32	Speculation Arg1:T88 Arg2:T15
A3	Assertion T15 Speculated
R33	Before Arg1:T6 Arg2:T7	
R34	Before Arg1:T6 Arg2:T8	
#71	AnnotatorNotes T2	C0021368; Inflammation; Pathologic Function + C0242606; Oxidative Stress; Cell or Molecular Dysfunction (?)
#72	AnnotatorNotes T32	C0021368; Inflammation; Pathologic Function + C0242606; Oxidative Stress; Cell or Molecular Dysfunction (?)
T90	Observation 473 479	efecto
#73	AnnotatorNotes T90	C1518681; Outcome of Therapy; Finding (?)
R35	Causes Arg1:T71 Arg2:T90	
R36	Overlap Arg1:T19 Arg2:T84	
R38	Overlap Arg1:T20 Arg2:T84	
R39	Overlap Arg1:T21 Arg2:T84	
R40	Overlap Arg1:T22 Arg2:T84	
R60	Overlap Arg1:T23 Arg2:T84	
R61	Overlap Arg1:T42 Arg2:T84	
R62	Overlap Arg1:T44 Arg2:T84	
R63	Overlap Arg1:T45 Arg2:T84	
#74	AnnotatorNotes T89	C0815129; anthropometric measurement; Quantitative Concept
R64	Experiences Arg1:T59 Arg2:T80	
#75	AnnotatorNotes T82	C2826279; Abnormal Finding; Finding
#76	AnnotatorNotes T87	C2826279; Abnormal Finding; Finding
#77	AnnotatorNotes T75	C4553389; Study Control; Conceptual Entity
A4	Experiencer T58 Patient
A5	Experiencer T59 Patient
A6	Experiencer T60 Patient
A7	Experiencer T63 Patient
A8	Experiencer T64 Patient
A9	Experiencer T67 Patient
